Secondly, we constructed a lysosomal-related gene signature consisting of CLN3, GBA, CTSA, BSG, APLN, SORT1, ANXA2, and LAPTM4B, which demonstrated high performance in the diagnosis and prognosis of HCC patients. The gene discussed is APLN; the disease is hepatocellular carcinoma.